Get the Stockscreener App
87.78
0.23%
-0.20
Lemaitre Vascular Inc stock is traded at $87.78, with a volume of 118.48K.
It is down -0.23% in the last 24 hours and up +3.27% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$87.98
Open:
$88.1
24h Volume:
118.48K
Relative Volume:
0.73
Market Cap:
$1.99B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
47.97
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+1.14%
1M Performance:
+3.27%
6M Performance:
-5.23%
1Y Performance:
-9.45%
1-Day Range:
$85.96
$88.10
1-Week Range:
$85.84
$88.72
52-Week Range:
$71.42
$105.55
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
87.78 | 2.00B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 - GlobeNewswire
Sentiment Recap: Is LeMaitre Vascular Inc stock showing strong momentum - baoquankhu1.vn
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Ranger Investment Management L.P. Lowers Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors - Sahm
3 Small-Cap Stocks We Keep Off Our Radar - Finviz
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 20% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
(LMAT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Rally Mode: Does LeMaitre Vascular Inc have pricing power2025 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
How (LMAT) Movements Inform Risk Allocation Models - Stock Traders Daily
Those who invested in LeMaitre Vascular (NASDAQ:LMAT) three years ago are up 92% - Yahoo Finance
LeMaitre Vascular, Inc. $LMAT Shares Bought by Vest Financial LLC - MarketBeat
LeMaitre Vascular (LMAT) Valuation Check After Mixed Share Performance And Growth Trends - Sahm
LeMaitre Vascular, Inc. (LMAT) Stock Report: Analyzing 17.44% Potential Upside with Strong Revenue Growth - DirectorsTalk Interviews
How LeMaitre Vascular Inc. (LHU) stock compares with top peersJuly 2025 Technicals & Growth Focused Entry Reports - bollywoodhelpline.com
SG Americas Securities LLC Makes New $1.10 Million Investment in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Does Analyst Optimism on Innovation and Global Expansion Reshape the Bull Case for LeMaitre Vascular (LMAT)? - Sahm
Conestoga Capital Advisors, LLC Adjusts Holdings in LeMaitre Vas - GuruFocus
Buy Signal: Is LeMaitre Vascular Inc stock showing strong momentumJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
LeMaitre Vascular (LMAT) Shares Cross Above 200 DMA - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Possible Bearish Signals With LeMaitre Vascular Insiders Disposing Stock - 富途牛牛
Trading Systems Reacting to (LMAT) Volatility - Stock Traders Daily
LeMaitre Vascular, Inc. $LMAT Shares Sold by Summit Creek Advisors LLC - MarketBeat
Conestoga Capital Advisors LLC Cuts Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
1 Cash-Producing Stock with Solid Fundamentals and 2 We Ignore - Finviz
How LeMaitre Vascular Inc. stock performs in rising dollar environmentJuly 2025 Action & Verified Technical Trade Signals - Улправда
Is LeMaitre Vascular Inc. stock gaining market share2025 Market WrapUp & Long Hold Capital Preservation Tips - Улправда
Why LeMaitre Vascular Inc. stock is trending among retail traders2025 Investor Takeaways & Safe Swing Trade Setup Alerts - Улправда
Why retail investors pile into LeMaitre Vascular Inc. stockJuly 2025 Summary & Long-Term Growth Plans - Улправда
Is LeMaitre Vascular Inc. stock a top pick in earnings season2025 Short Interest & Real-Time Market Sentiment Alerts - ulpravda.ru
What is the fair value estimate for LeMaitre Vascular Inc. (LHU) stock in 2025July 2025 Decliners & High Accuracy Investment Entry Signals - Улправда
What risks investors should watch in LeMaitre Vascular Inc. stockJuly 2025 Closing Moves & Reliable Price Breakout Signals - Улправда
Is LeMaitre Vascular Inc. stock attractive for retirement portfolios2026 world cup usa national team group stage goalkeepers pressing system expert forecast insights - ulpravda.ru
Do LeMaitre Vascular's (NASDAQ:LMAT) Earnings Warrant Your Attention? - Yahoo Finance
2026 world cup tactical analysis rankings: Is LeMaitre Vascular Inc. stock attractive for retirement portfolios2026 world cup usa national team third place match young talents high defensive line knockout prediction preview - Улправда
Options Flow: Why retail investors pile into LeMaitre Vascular Inc stockMarket Weekly Review & Growth Focused Stock Reports - moha.gov.vn
LMAT6268257 Bond Analysis — Key Metrics - TradingView — Track All Markets
สล็อต ทดลองเล่นฟรี ถอนได้ - earlytimes.in
LeMaitre Vascular (NASDAQ:LMAT) Cut to “Hold” at Zacks Research - Defense World
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Shares May Have Run Too Fast Too Soon - simplywall.st
LeMaitre Vascular (NASDAQ:LMAT) Downgraded by Zacks Research to "Hold" - MarketBeat
How Lemaitre Vascular Inc. (LMAT) Affects Rotational Strategy Timing - Stock Traders Daily
LeMaitre Vascular, Inc. $LMAT Shares Sold by Copeland Capital Management LLC - MarketBeat
Will LeMaitre Vascular Inc. stock beat EPS estimatesReal-Time Stock Alerts & Low Cost Trading Plans - bollywoodhelpline.com
Harbor Capital Advisors Inc. Trims Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Fed Watch: What analyst consensus implies for LeMaitre Vascular Inc LHU stockSwing Trade & Real-Time Sentiment Analysis - moha.gov.vn
Hedge Fund Bets: What analyst consensus implies for LeMaitre Vascular Inc LHU stockEarnings Growth Summary & Stock Portfolio Risk Management - moha.gov.vn
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):